InspireMD (NSPR) News Today $3.00 -0.22 (-6.83%) Closing price 04:00 PM EasternExtended Trading$3.24 +0.25 (+8.17%) As of 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period InspireMD (NYSE:NSPR) Now Covered by StockNews.comStockNews.com began coverage on shares of InspireMD in a research report on Sunday. They set a "sell" rating on the stock.March 2 at 2:09 AM | marketbeat.comNSPR stock touches 52-week high at $3.43 amid robust growthFebruary 26, 2025 | investing.comInspireMD to Announce Fourth Quarter and Full Year 2024 Financial ResultsFebruary 26, 2025 | globenewswire.comInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 25, 2025 | globenewswire.comInvestors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five yearsFebruary 24, 2025 | finance.yahoo.comInspireMD participates in a conference call with Lake StreetFebruary 14, 2025 | markets.businessinsider.comInspireMD (NYSE:NSPR) Coverage Initiated at StockNews.comStockNews.com began coverage on InspireMD in a research note on Friday. They issued a "sell" rating on the stock.February 14, 2025 | marketbeat.comInspireMD, NAMSA partner on CGUARDIANS II trial of CGuard PrimeFebruary 13, 2025 | markets.businessinsider.comInspireMD (NSPR) Receives a Buy from Lake StreetFebruary 13, 2025 | markets.businessinsider.comInspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR proceduresFebruary 13, 2025 | globenewswire.comInspireMD announces inducement grants under Nasdaq listing ruleFebruary 4, 2025 | markets.businessinsider.comInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 4, 2025 | globenewswire.comInspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.comStockNews.com began coverage on InspireMD in a report on Wednesday. They issued a "sell" rating on the stock.January 29, 2025 | marketbeat.comInspireMD announces inducement grantsJanuary 22, 2025 | markets.businessinsider.comStockNews.com Initiates Coverage on InspireMD (NYSE:NSPR)StockNews.com assumed coverage on shares of InspireMD in a report on Tuesday. They issued a "sell" rating on the stock.January 21, 2025 | marketbeat.comHere's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn SituationJanuary 14, 2025 | finance.yahoo.comStockNews.com Begins Coverage on InspireMD (NYSE:NSPR)StockNews.com started coverage on InspireMD in a research report on Sunday. They set a "sell" rating on the stock.January 5, 2025 | marketbeat.comInspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.comStockNews.com began coverage on InspireMD in a report on Friday. They issued a "sell" rating for the company.December 20, 2024 | marketbeat.comInspireMD, Inc.: InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025December 12, 2024 | finanznachrichten.deInspireMD Finance Chief Craig Shore To RetireDecember 12, 2024 | markets.businessinsider.comInspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025December 12, 2024 | finance.yahoo.comLake Street Initiates Coverage of InspireMD (NSPR) with Buy RecommendationDecember 12, 2024 | msn.comInspireMD initiated with a Buy at Lake StreetDecember 11, 2024 | markets.businessinsider.comInspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)December 9, 2024 | globenewswire.comInspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of DirectorsNovember 26, 2024 | finance.yahoo.comInspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of DirectorsNovember 25, 2024 | globenewswire.comInspireMD, Inc. (II2.F)November 21, 2024 | nz.finance.yahoo.comInspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comInspireMD Inc. Reports Q3 2024 Financial ResultsNovember 13, 2024 | markets.businessinsider.comInspireMD Inc (NSPR) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Costs and ...November 13, 2024 | finance.yahoo.comInspireMD Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 12, 2024 | markets.businessinsider.comWhat To Expect From InspireMD Inc (NSPR) Q3 2024 EarningsNovember 11, 2024 | finance.yahoo.comInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 8, 2024 | globenewswire.comInspireMD (NSPR) Set to Announce Earnings on TuesdayInspireMD (NYSE:NSPR) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 5, 2024 | marketbeat.comInspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12thNovember 4, 2024 | finance.yahoo.comInspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.comStockNews.com initiated coverage on InspireMD in a report on Friday. They issued a "sell" rating on the stock.October 25, 2024 | marketbeat.comOne InspireMD Insider Raised Stake By 13% In Previous YearOctober 22, 2024 | finance.yahoo.comInspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent SystemOctober 15, 2024 | globenewswire.comInspireMD Inc (NSPR) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ChallengesOctober 9, 2024 | finance.yahoo.comInspireMD (NYSE:NSPR) Research Coverage Started at StockNews.comStockNews.com initiated coverage on shares of InspireMD in a research note on Wednesday. They issued a "sell" rating for the company.October 9, 2024 | marketbeat.comInspireMD Advances with FDA Study Approval and Global GoalsOctober 8, 2024 | finance.yahoo.comInspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent SystemOctober 7, 2024 | globenewswire.comInspireMD (NSPR) Receives a Buy from Piper SandlerSeptember 18, 2024 | markets.businessinsider.comInspireMD (NYSE:NSPR) Given Overweight Rating at Piper SandlerPiper Sandler reissued an "overweight" rating and set a $4.50 price objective on shares of InspireMD in a research report on Tuesday.September 17, 2024 | marketbeat.comInspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent SystemSeptember 16, 2024 | globenewswire.comInvestors in InspireMD (NASDAQ:NSPR) have unfortunately lost 88% over the last five yearsSeptember 14, 2024 | finance.yahoo.comInspireMD, Inc. (NSPR) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comNexstar Media GAAP EPS of $3.54 misses by $0.11, revenue of $1.27B misses by $10MAugust 8, 2024 | msn.comInspireMD, Inc.: InspireMD Congratulates CREST-2 Investigators on Completion of Trial EnrollmentAugust 7, 2024 | finanznachrichten.deR1 RCM Reports Second Quarter 2024 ResultsAugust 7, 2024 | markets.businessinsider.com Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address NSPR Media Mentions By Week NSPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NSPR News Sentiment▼-0.090.71▲Average Medical News Sentiment NSPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NSPR Articles This Week▼51▲NSPR Articles Average Week Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZIMV News Today LUNG News Today NYXH News Today TCMD News Today NNOX News Today CVRX News Today SMTI News Today AVR News Today RCEL News Today INGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NSPR) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
